866-997-4948(US-Canada Toll Free)

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

Published By :

GlobalData

Published Date : Feb 2015

Category :

Bladder Cancer

No. of Pages : 69 Pages

 

GlobalData's clinical trial report, Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015" provides data on the Muscle Invasive Bladder Cancer (MIBC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Invasive Bladder Cancer (MIBC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Table of Contents

 

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Muscle Invasive Bladder Cancer (MIBC) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Muscle Invasive Bladder Cancer (MIBC) 24

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Celldex Therapeutics, Inc. 31

Clinical Trial Overview of Celldex Therapeutics, Inc. 31

Astellas Pharma Inc. 32

Clinical Trial Overview of Astellas Pharma Inc. 32

Clinical Trial Overview of Top Institutes / Government 33

Memorial Sloan Kettering Cancer Center 33

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33

Fox Chase Cancer Center 34

Clinical Trial Overview of Fox Chase Cancer Center 34

Trans Tasman Radiation Oncology Group 35

Clinical Trial Overview of Trans Tasman Radiation Oncology Group 35

Brown University 36

Clinical Trial Overview of Brown University 36

Centre Val d'Aurelle - Paul Lamarque 37

Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque 37

Nara Medical University 38

Clinical Trial Overview of Nara Medical University 38

Hiroshima University Hospital 39

Clinical Trial Overview of Hiroshima University Hospital 39

Hirosaki University 40

Clinical Trial Overview of Hirosaki University 40

Sun Yat-sen University 41

Clinical Trial Overview of Sun Yat-sen University 41

Tata Memorial Hospital 42

Clinical Trial Overview of Tata Memorial Hospital 42

Five Key Clinical Profiles 43

 

Appendix 66

Abbreviations 66

Definitions 66

Research Methodology 67

Secondary Research 67

About GlobalData 68

Contact Us 68

Disclaimer 68

Source 69

List of Table

 

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015* 31

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 32

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 33

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 34

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Trans Tasman Radiation Oncology Group, 2015* 35

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2015* 36

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2015* 37

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nara Medical University, 2015* 38

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 39

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hirosaki University, 2015* 40

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 41

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2015* 42

List of Chart

 

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 67

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *